Tag: EMBO-02
EMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast...
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic...
Arsenal Medical launches EMBO-02 study to assess NeoCast in cSDH treatment
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a...
